In this section of the Cytosorbents Newsroom, you'll find our news releases. The releases are listed in chronological order and are archived by year.
-
-
-
-
Mar 9, 2021
2020 Total Revenue was $41.0 million, with 2020 Product Sales of $39.5 million, up 73% over 2019. Achieved record Product Gross Margins of 82% for Q4 2020
-
Mar 2, 2021
Joint marketing of CytoSorb® with B. Braun's newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.